EUVIMEDEUVIMED entdecken
Crossref

Formulation and in Vitro Evaluation of Niacin 500 Mg Extended Release Tablets

Kranthi Kumar K, Udaykumar Thummala, Nageswara Rao Samidala, Pulagurtha Bhaskararao, Kumar CSP

International Journal of Drug Delivery Technology · 21.01.2026 · 16 (01)

DOI: 10.25258/ijddt.16.1.33 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 21.01.2026. Verfasst von Kranthi Kumar K und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study aimed to develop and optimize Niacin 500 mg extended release (ER) tablets to address challenges associated with conventional formulations, such as frequent dosing and adverse effect like flushing and hepatotoxicity The novelty of the work lies in designing ER tablets using hydroxypropyl methylcellulose (HPMC) E10M and K15M polymers, comparing direct compression and wet granulation methods. Wet granulation with HPMC E10M was identified as superior based on in vivo dissolution and other evaluation parameters. A systematic formulation approach explored varying concentrations of polymer, binder, and lubricant across different batches (F1 to F13) to obtain optimal drug release profiles. F3 formulation demonstrated a gradual and extended release, closely matching the marketed product (MP) in in vitro dissolution equivalence studies with dissimilarity factor (f1) and similarity factors (f2) of 4.15% and 78.87%, respectively. Stability testing over two months under accelerated conditions confirmed the robustness of the optimized formulation, with consistent in vitro dissolution and physical attributes. Finally, the study successfully established a formulation for Niacin ER tablets (F3) that offers extended release, improved patient compliance, and less side effects, making it promising alternative for dyslipidemia management.

Zitieren

APA

K, K. K., Thummala, U., Samidala, N. R., Bhaskararao, P., & CSP, K. (2026). Formulation and in Vitro Evaluation of Niacin 500 Mg Extended Release Tablets. International Journal of Drug Delivery Technology, 16(01). https://doi.org/10.25258/ijddt.16.1.33

Vancouver

K KK, Thummala U, Samidala NR, Bhaskararao P, CSP K. Formulation and in Vitro Evaluation of Niacin 500 Mg Extended Release Tablets. International Journal of Drug Delivery Technology. 2026;16(01). doi:10.25258/ijddt.16.1.33

BibTeX
@article{K2026,
  author = {K, Kranthi Kumar and Thummala, Udaykumar and Samidala, Nageswara Rao and Bhaskararao, Pulagurtha and CSP, Kumar},
  title = {Formulation and in Vitro Evaluation of Niacin 500 Mg Extended Release Tablets},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {01},
  doi = {10.25258/ijddt.16.1.33}
}
Kostenlos starten →